Joined March 2024
143 Photos and videos
Congratulations to Dr. Moataz Ellithi on being named a 2026 @ConquerCancerFd Career Development Award recipient! 🎉 @EllithiMd #CancerResearch
1
3
5
195
More people than ever are living beyond cancer—and the field is rising to meet them. Read how Fred & Pamela Buffett Cancer Center researchers are helping shift the focus from surviving to thriving: unmc.edu/newsroom/2026/06/08… #NationalCancerSurvivorsMonth
28
A major milestone for #cancercare in #Nebraska. Nebraska’s first #proton beam therapy system has been delivered to the University of Nebraska Medical Center, bringing innovative treatment technology closer to patients across the region. KETV news: go.unmc.edu/z7qy
493
Join us today for Let’s Chat Cancer in collaboration with World Speaks! As part of Language Access Week, we’ll discuss #BreastCancer in the Latine Community and explore the importance of education, awareness and access to care.
1
1
76
Congrats @VijayaRBhatt1!
Mina Sedrak and Vijaya Raj Bhatt to co-lead @Alliance_org's committee on cancer care for older adults cancerletter.com/in-brief/20…
2
89
The Cattlemen's Ball of Nebraska brings communities together to support cancer research. A few glimpses from our time at the Ball '26. #CattlemensBall #CancerResearch #Nebraska #CattlemensBall26
1
1
1
172
The @BigTenCRC has launched the Big Ten Cancer Connections podcast — starting with "Women in Myeloma," featuring our own Dr. Tanya Wildes and myeloma colleagues from across the consortium! Listen here: bigtencancerconnections.rive…
1
227
Fred & Pamela Buffett Cancer Center retweeted
Happening now at #ASCO26: Kelsey Klute, MD (@DrKelseyKlute @BuffettCancer), reviews practice-changing updates in GI cancers. Key highlights: • Potential new 1L standard for HER2 metastatic gastroesophageal cancer (HERIZON-GEA-01). • Improved outcomes with combined local and systemic therapy in unresectable HCC (EMERALD-3). • Daraxonrasib doubled survival and improved quality of life in previously treated metastatic pancreatic cancer, setting a new standard of care (RASolute-302). #MoffittASCO26
7
14
494
Stop by Hall A – 9:00 AM–12:00 PM, tomorrow, to hear Dr. @AparGanti present findings from a study with more than 2,000 patients comparing two immunotherapy agents for extensive-stage small cell lung cancer. #ASCO2026 Abstract 8093: asco.org/abstracts-presentat…
2
240
Nikhila Aimalla, MBBS, presents findings from a SEER analysis of more than 7,300 patients with thymic carcinoma—the largest study of this rare malignancy to date! #ASCO2026 Abstract e20169: asco.org/abstracts-presentat…
3
2
425
Tomorrow at #ASCO26 @DrKelseyKlute will lead the Highlights of the Day session for Upper GI, Hepatobiliary & Pancreatic Cancers summarizing key research advances and emerging therapies that could help shape the future of pancreatic cancer care. June 2 | 8:00–8:15 AM | Hall D1
7
6
629
Yinting Liu presents at #ASCO2026 findings from a study evaluating the impact of treatment sequencing between immunotherapy and stereotactic radiotherapy in patients with metastatic non-small cell #LungCancer. Abstract e20119: asco.org/abstracts-presentat…
2
163
Fred & Pamela Buffett Cancer Center retweeted
Replying to @BuffettCancer
@BuffettCancer #ASCO2026 reception! Thanks for all who joined us this evening - so proud to be a part of this team caring for Nebraskans with cancer. @joshuamammen @DrJulieVose @AparGanti @lymphomaphilia
1
5
15
947
Stop by Hall A – 9 AM–12 PM, Monday, June 1, hear from Dr. Tanya Wildes present at #ASCO2026 findings from a Phase II trial evaluating iberdomide (Iber) maintenance therapy following autologous stem cell transplant (ASCT) in patients with #MultipleMyeloma.
1
2
1
333
Abram Arnold, DO, presents at #ASCO2026 results from a single-center retrospective analysis evaluating the best treatment sequence to help guide treatment planning for patients with pancreatic cancer. Abstract e16467: lnkd.in/dAGg7bYw #PancreaticCancer #CancerResearch
2
597
Dr. Omar Abughanimeh presents results from a 10-year study showing how patient’s overall health & ability to perform everyday activities before treatment may play an important role in how well they respond to combination immunotherapies #ASCO2026 @omarabughanimeh
5
9
604
From lung & hematologic cancers to breast, gynecologic, & GI oncology, Buffett Cancer Center researchers will present impactful science at ASCO 2026—spanning immunotherapy, targeted cellular therapies and precision medicine. Read more: go.unmc.edu/98jw #ASCO2026 #Oncology
2
4
226